Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Alzheimer's / Dementia News

Cellumen Partners With Alzheimer's Drug Discovery Foundation To Develop New Assays For Early Treatment Of Alzheimer's

Main Category: Alzheimer's / Dementia
Article Date: 02 Oct 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:4 stars

3.67 (3 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Cellumen, Inc. announced an agreement with the Alzheimer's Drug Discovery Foundation (ADDF) to apply Cellumen's Cellular Systems Biology (CSB) technology to create a cellular model of Alzheimer's disease.

The main objective of the partnership is for Cellumen to develop a panel of CSB assays, as well as biosensors of key protein:protein interactions, that reveal the activity of multiple targets and pathways implicated in Alzheimer's disease in an intact, functioning cellular system.

"Our alliance with the Alzheimer's Drug Discovery Foundation allows Cellumen to implement its Cellular Systems Biology expertise to enable lead discovery for Alzheimer's disease," says D. Lansing Taylor, Ph.D., CEO of Cellumen. "We have the opportunity to revolutionize the treatment of this complex disease by providing pharmaceutical companies with the necessary tools to identify novel chemical modulators of the AD systems biology. Our ability to use the cell as an integrated, interactive network of genes, proteins, and metabolites sets us apart, and enables us to address this unmet medical need."

"Cellumen is on the cutting edge of building cellular models of disease, thus accelerating the discovery process for systems-based diseases such as Alzheimer's," says Howard Fillit, M.D., Executive Director of the ADDF.

About Cellumen

Cellumen is the leading innovator in cellular systems biology (CSB™) solutions providing the most accurate predictions of drug efficacy and safety, thus reducing failure rates and cutting development costs. Cellumen's CSB solutions are driving Discovery Toxicology by addressing the full complexity of disease and safety. Leading global organizations, such as the Mayo Clinic, Hamamatsu Photonics K.K., the EPA, FDA, NIH, and top pharmaceutical companies, partner with Cellumen. Cellumen is a partner company of Safeguard Scientifics. Other investors include Novitas Capital, the Pittsburgh Life Sciences Greenhouse, and Innovation Works. For more information about Cellumen, please visit http://www.Cellumen.com.

About Alzheimer's Drug Discovery Foundation

The ADDF is an affiliated public charity of the Institute for the Study of Aging (ISOA), a private foundation founded by the Estèe Lauder family in 1998. The charity was established in 2004 to enable the public to work with us in advancing our common mission of supporting scientists pursuing drug discovery research for Alzheimer's disease, related dementias and cognitive aging.

Alzheimer's Drug Discovery Foundation




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Researchers Find Possible Environmental Causes For Alzheimer's, Diabetes
07 Jul 2009
A new study by researchers at Rhode Island Hospital have found a substantial link between increased levels of nitrates in our environment and food, with increased deaths from diseases, including Alzheimer's, diabetes mellitus and Parkinson's...


The Role of a Caregiver image The Role of a Caregiver

When a frail or chronically ill loved one can no longer care for him or herself the issue confronting families is what to do about care. Learn what you need to think about first...

Using Creativity to Combat Alzheimer's image Using Creativity to Combat Alzheimer's

Learn how the introduction of a new activity changed the lives of an Alzheimer's patient and her caregiver...

View more videos...